Guidance & Assistance
for Stakeholders in Flanders
on European funding programmes
The European Partnership on One Health Antimicrobial Resistance (OH AMR) is about to launch the joint transnational call 2027 (JTC2027) “Understand, Model and Stop AMR Transmission”. The call opens on 18 November 2026. The call will follow a two-step evaluation process.Novel and improved measures are urgently required...
Read moreThe European Commission Directorate-General Research & Innovation has published ERA in Practice: A Guide for the R&I Community, developed with the support of INSPIRING ERA. The publication connects the four European Research Area policy priorities for joint action of the Pact for Research and Innovation (2021), with practical tools and...
Read moreNet4Society, the NCP network for Cluster 2, has published an updated edition of the document "Opportunities for Researchers from the Social Sciences and Humanities (SSH) in Horizon Europe". This document is designed to help potential applicants to find SSH-related call topics across the different parts of Horizon Europe in Work Programmes...
Read moreOn 5 November 2026, the European Commission published a correction for Horizon Europe topic HORIZON-CL6-2027-02-FARM2FORK-05. Under the section ‘Topic description - Scope’, the sentence on collaboration with projects funded under other topics in the work programme has been updated. The original text referred to...
Read moreEIT Health (European Institute of Innovation and Technology) has launched its Innovation Validation Call for 2027. It offers fundingfor projects focusing on digital and AI-enabled medical technologies approaching market launch. Funding covers clinical studies and evidence collection to assess safety and efficacy, support regulatory approval and...
Read moremyOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
Free tools to find your way in European funding.
EIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...
Read moreThis one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.
Read moreThe European Commission’s flagship research and innovation event aims to bring together policymakers, researchers, innovators, business leaders and representatives of civil society. It is designed to look at how research and innovation can strengthen Europe’s competitiveness, resilience and technological sovereignty. The programme is expected to include high-level policy discussions, breakout sessions, networking opportunities, award ceremonies and exchanges with EU Science Counsellors.
Read moreThis event looks at how environmental research contributes to Europe’s competitiveness, resilience, strategic autonomy and security. The programme aims to combine high-level policy reflections, examples of research impact and a discussion on the future direction of European environmental research. It ends with a networking reception marking...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
